Preview

Medical alphabet

Advanced search

Prognosis of development of complications of cardiogenic shock and pulmonary edema in patients with myocardial infarction on background of obstructive pulmonary disease

https://doi.org/10.33667/2078-5631-2020-36-34-37

Abstract

Objective. To create a personalized mathematical model of the development of complications – cardiogenic shock and pulmonary edema in patients with myocardial infarction (MI) with chronic obstructive pulmonary disease (COPD) depending of the homocysteine (HCY) level and the COPD phenotype.

Materials and methods. The study included 88 patients with MI and COPD with various phenotypes: 25 patients with emphysematous phenotype, 22 patients with a mixed phenotype, 20 patients with chronic bronchitis phenotype, 21 patients with eosinophilia and bronchial asthma (BA). As a control group, 50 somatically healthy individuals were examined. Gender anamnestic, clinical, and laboratory – instrumental indicators were studied and analyzed to develop a predictive mathematical model. The level of HCY was determined by enzyme-linked immunosorbent assay in all patients.

Results. It was found that in patients with MI and COPD with different COPD phenotypes, the level of HCY was statistically significantly higher than in the control group. The highest level of HCY was in patients with the chronic bronchitis phenotype and was 45 [14.1; 51.9] mmol/l, which was statistically significantly higher than in patients with the phenotype with eosinophilia and BA, with emphysematous and mixed phenotypes. Predictor factors were selected using the logit regression method from gender-anamnestic, clinical, and laboratory – instrumental indicators to create a mathematical model with the highest prediction accuracy. HCY level and COPD phenotype were predictors of the mathematical model for predicting the development of complications – cardiogenic shock and pulmonary edema in patients with MI and COPD. It was also found that the threshold value of HCY for predicting the development of cardiogenic shock and pulmonary edema in patients with MI and COPD was 0.82 ± 0.51 confidence interval [0.72–0.91] mmol/l (p < 0.001).

Conclusion. The personalized mathematical model initiated for predicting the development of complications-cardiogenic shock and pulmonary edema in patients with MI and COPD, depending of the HCY level and the COPD phenotype, has a high sensitivity (85%) and prognostic significance (92%), which allows us to recommend it for use in clinical practice.

About the Authors

B. Yu. Kuzmichev
Astrakhan State Medical University
Russian Federation
Astrakhan


O. S. Polunina
Astrakhan State Medical University
Russian Federation
Astrakhan


L. P. Voronina
Astrakhan State Medical University
Russian Federation
Astrakhan


T. V. Prokofieva
Astrakhan State Medical University
Russian Federation
Astrakhan


E. A. Polunina
Astrakhan State Medical University
Russian Federation
Astrakhan


References

1. Будневский А.В., Малыш Е.Ю. Хроническая обструктивная болезнь легких как фактор риска развития сердечно-сосудистых заболеваний. Кардиоваскулярная терапия и профилактика. 2016; 15 (3): 69–73. DOI: 10.15829/1728–8800–2016–3–69–73.

2. Bhatt S.P., Nanda S., Kintzer J. S. Arrhythmias as trigger for acute exacerbations of chronic obstructive pulmonary disease. Respir Med. 2012; 106: 1134–8. DOI: 10.1016/j.rmed.2012.04.007.

3. Уклистая Т.А. Субклиническое воспаление, антиоксидантный статус и состояние вегетативной регуляции сердечного ритма у больных хронической обструктивной болезнью легких в сочетании с ишемической болезнью сердца. Вестник новых медицинских технологий. 2016: 23 (2): 61–66. DOI: 10.12737/20426.

4. Игнатова Г.Л., Антонов В.Н. Прогностические индексы и маркеры системного воспаления у пациентов с ХОБЛ и ИБС. Медицинский совет. 2017; 4: 81–85. DOI: 10.21518/2079–701X2017–4–81–85.81–85.

5. Donaldson G. C., Hurst J. R., Smith C. J., Hubbard R. B., Wedzicha J.A. Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest. 2010; 137: 1091–1097. DOI: 10.1378/chest.09–2029.

6. Zhang J.W., Zhou Y.J., Yang Q., Yang S.W., Nie B., Xu XH. Impact of chronic obstructive pulmonary diseases on outcomes and hospital days after percutaneous coronary intervention. Angiology. 2013; 64: 430–434. DOI: 10.1177/0003319712458145.

7. Бекенова Д.З., Демидов А.А., Сагитова Г.Р., Давлетова Г.З. Сравнительная характеристика активности маркеров иммунного воспаления при неблагоприятном исходе острого Q-образующего инфаркта миокарда. Медицинская иммунология. 2015; 17 (S): С. 288.

8. Serban R.C., Hadadi L.,Sus I., Lakatos E.K., Demjen Z., Scridon A. Impact of chronic obstructive pulmonary disease on in-hospital morbidity and mortality in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention. Int J Cardiol. 2017; 243: 437–442. DOI: 10.1016/j.ijcard.2017.05.044.

9. De Bree A., Verschuren W. M., Kromhout D., Kluijtmans L. A., Blom H.J. Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease. Pharmacol Rev. 2002; 54: 599–618. DOI: 10.1124/pr.54.4.599.

10. Werstuck G.H., Lentz S.R., Dayal S., Hossain G.S., Sood S.K., Shi Y.Y., Zhou J., Maeda N., Krisans S.K., Malinow M.R., Austin R.C. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J. Clin Invest. 2001; 107: 1263–73. DOI: 10.1172/JCI11596.

11. Yeh J.K., Chen C.C., Hsieh M. J., Tsai M. L., Yang C.H., Chen D.Y., Chang S.H., Wang C.Y., Lee C.H., Hsieh I.C. Impact of Homocysteine Level on Long-term Cardiovascular Outcomes in Patients after Coronary Artery Stenting. J Atheroscler Thromb. 2017; 24 (7): 696–705. DOI: 10.5551/jat.36434.

12. Kai S., Nomura A., Morishima Y., Ishii Y., Sakamoto T., Hegab A.E., Sekizawa K. The effect of smoking-related hyperhomocysteinemia on spirometric declines in chronic obstructive pulmonary disease in elderly Japanese. Arch Gerontol Geriatr. 2006; 42 (2): 117–24. DOI: 10.1016/j.archger.2005.06.003


Review

For citations:


Kuzmichev B.Yu., Polunina O.S., Voronina L.P., Prokofieva T.V., Polunina E.A. Prognosis of development of complications of cardiogenic shock and pulmonary edema in patients with myocardial infarction on background of obstructive pulmonary disease. Medical alphabet. 2020;(36):34-37. (In Russ.) https://doi.org/10.33667/2078-5631-2020-36-34-37

Views: 295


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2078-5631 (Print)
ISSN 2949-2807 (Online)